WHAT TO DO
WHEN YOUR BANK OR LENDER SAYS "NO"
A bank rejection shouldn’t freeze your research. Discover how Bios Analytique’s specialist operating leases and Ultra Flex plans keep UK laboratories moving without hitting your balance sheet.
Traditional lenders rely on rigid algorithms that simply fail to grasp the value of high-tech analytical equipment. In commercial science, waiting for the next funding round means moving backward. Our industry-specific financing bypasses traditional roadblocks, converting major equipment upgrades into manageable, tax-efficient operating expenses. Don’t let bureaucratic delays stall your scientific breakthroughs; switch to a financial partner that understands your technology.
THE COST OF A "NO"
IN THE LIFE SCIENCES SECTOR
The email arrives from your lender asset finance department: Application Declined.
You’ve spent months calculating the ROI, configuring the technical specifications, and identifying the exact chromatography or mass spectrometry system your lab needs to scale. Perhaps it’s a critical upgrade to your setup, or the specialized IT software required to keep your data compliant.
Your science is ready. Your team is ready. Your growth strategy depends on it.
For most laboratory managers, and CFOs in the UK Biotech and Pharmaceutical sectors, this feels like a brick wall. Traditional lenders operate on rigid, outdated credit algorithms. They look at a high-tech laboratory and see risk, not potential. They demand upfront deposits, ask for director guarantees, or simply fail to understand why a piece of analytical equipment costs what it does.
The temptation is to hit the brakes, downscale your research goals, or wait for the next funding round. But in commercial science, standing still is the same as moving backward.
A financial rejection isn’t proof that your project isn’t viable. It is simply proof that you are talking to the wrong financial partner.
WHY FINANCIAL INSTITUTIONS
OFTEN MISUNDERSTAND LABORATORY ASSETS
Traditional UK banks are designed to finance bricks, mortar, and fleet vehicles. When they evaluate a cutting-edge laboratory, their rigid risk models fail to accurately assess the value of scientific instrumentation.
Here is why a rejection from a mainstream bank is often a reflection of their limitations, not your laboratory’s potential:
The Traditional Route
The Bios Analytique Approach
Rigid Risk Algorithms
They evaluate your lab using the same generic metrics they apply to retail or hospitality businesses.
Scientific Industry Experts
We understand the technology, the manufacturers , and the true residual value of the assets.
Heavy CapEx/Debt Burden
They push you toward high-interest loans that sit as a heavy liability on your balance sheet.
Smart OPEX Management
Our operating leases keep your balance sheet clean and protect your debt-to-equity ratios.
The Obsolescence Trap
They lock you into long-term ownership of an asset that may be technologically outdated in 36 months.
Future-Proof Flexibility
We structure agreements that allow you to upgrade or scale your technology as your research evolves.
Slow & Bureaucratic Processes
They drag you through weeks of paperwork and committees, completely disconnected from the fast-paced timeline of commercial science.
Agile & Focused Approvals
We deliver decisions in 24/48h tailored to your project’s urgency, ensuring your research never grinds to a halt.
MOVING FORWARD:
THREE SMARTER WAYS TO FUND YOUR LAB EQUIPMENT
When your lender closes a door, Bios Analytique opens a bespoke pathway. Because we specialise exclusively in laboratory and scientific equipment finance, we can offer flexible frameworks that lenders simply cannot replicate.
If your lab is facing a funding bottleneck, here is how we get your project back on track:
1. Tailored Operating Leases
Don't tie up precious working capital in rapidly depreciated hardware. With a Bios Operating Lease, you only pay for the usage of the equipment.
2. The Ultra Flex Plan
In commercial science, project scopes change, grants get delayed, and market demands shift. Our Ultra Flex plan is designed for ultimate flexibility.
3. "All-In-One" Technology & Software
A traditional bank will rarely finance the "invisible" but vital components of a lab upgrade, such as specialist software, network integration, and ongoing maintenance.
FREQUENTLY ASKED QUESTIONS
A bank loan is a form of debt that funds an asset purchase, meaning the equipment sits on your balance sheet as a depreciating asset and increases your liabilities. A Bios Analytique Operating Lease allows you to pay purely for the use of the equipment over a fixed term. Because it is treated as an Operating Expense (OPEX), it does not dilute your debt-to-equity ratio, preserves your borrowing power for other operational needs, and provides direct tax advantages.
Yes, absolutely. Traditional banks struggle to underwrite early-stage biotech or life science companies because they look for historical cash flows and traditional collateral. At Bios Analytique, we evaluate the commercial viability of both your project and business, the nature of the equipment , and your future growth. Our Ultra Flex plans are specifically designed to align with the unique funding milestones of scaling UK laboratories.
Absolutely. Mainstream lenders typically refuse to finance “soft costs” because they have no intrinsic value. Bios Analytique offers integrated technology financing. We can bundle your hardware, laboratory informatics software, validation services, and ongoing maintenance agreements into a single, straightforward monthly or quarterly payment.
No, you have options. Unlike rigid bank agreements, we offer multiple end-of-term options tailored to commercial science timelines. You can choose to upgrade to the latest technology (e.g., swapping an older mass spectrometer for a newer model), extend the lease at a reduced rate, or seamlessly transition to ownership. This eliminates the technology obsolescence risk common in modern laboratories.
Yes. While high-street banks almost universally refuse to finance used or refurbished laboratory assets due to rigid asset-age caps, Bios Analytique understands the real-world residual value of Tier-1 instrumentation. Whether you are acquiring brand-new systems or certified pre-owned chromatography equipment to stretch your funding further, we can structure a bespoke lease.
EXPLORE OUR FINANCING SOLUTIONS
We understand that every laboratory has unique needs. That’s why we offer tailored rental options designed for flexibility and speed.
Our goal is simple: deliver a ready-to-use solution with minimal downtime and maximum performance.
DISCOVER OUR LABORATORY INSTRUMENTS
AVAILABLE FOR RENT / LEASE
€ 1463 /month
2901 € /month
€ 400/month
€ 560 /month
676 € /month
€ 392 /month
1459 € /month
€ 642 /month
€ 1000 /month
€ 769 /month